In relation to this, CML cells express programmed cell death ligand 1 (PD-L1), and a high expression of PD-L1 on human CD34+ CML cells is a negative prognostic factor40,41. This evidence concerns the gene CD34 and chronic myelogenous leukemia, BCR-ABL1 positive.